Recent advances in therapies to control diabetes have revolutionized obese patient care 15
Your healthcare provider can perform appropriate monitoring, including HbA1c testing (at least twice yearly if stable and at goal, or quarterly if therapy has changed or targets are not met), fasting glucose measurements, weight tracking, and assessment of cardiovascular risk factors
As with all medicines, patients and healthcare professionals are advised to use GLP-1 receptor agonists in accordance with the approved product information
Inflammation and Vascular Risk GLP-1 medications are being studied for effects beyond appetite and weight
Vitamin B12: If you're a meat eater, chances are you're getting enough B12, which is primarily found in animal products
Life Outcomes 6 , 99 (2008)